These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 36649339)
1. Maximum Dose Rate of Intrapartum Oxytocin Infusion and Associated Obstetric and Perinatal Outcomes. Son M; Roy A; Grobman WA; Miller ES; Dude A; Peaceman AM; Stetson B Obstet Gynecol; 2023 Feb; 141(2):379-386. PubMed ID: 36649339 [TBL] [Abstract][Full Text] [Related]
2. High-Dose Compared With Standard-Dose Oxytocin Regimens to Augment Labor in Nulliparous Women: A Randomized Controlled Trial. Son M; Roy A; Stetson BT; Grady NT; Vanecko MC; Bond N; Swanson K; Grobman WA; Miller ES; Peaceman AM Obstet Gynecol; 2021 Jun; 137(6):991-998. PubMed ID: 33957657 [TBL] [Abstract][Full Text] [Related]
3. Induction of labor with misoprostol for premature rupture of membranes beyond thirty-six weeks' gestation. Wing DA; Paul RH Am J Obstet Gynecol; 1998 Jul; 179(1):94-9. PubMed ID: 9704771 [TBL] [Abstract][Full Text] [Related]
4. Oxytocin regimen for labor augmentation, labor progression, and perinatal outcomes. Zhang J; Branch DW; Ramirez MM; Laughon SK; Reddy U; Hoffman M; Bailit J; Kominiarek M; Chen Z; Hibbard JU Obstet Gynecol; 2011 Aug; 118(2 Pt 1):249-256. PubMed ID: 21775839 [TBL] [Abstract][Full Text] [Related]
5. High- vs low-dose oxytocin in lean and obese women: a double-blinded randomized controlled trial. Wei RM; Bounthavong M; Hill MG Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100627. PubMed ID: 35358738 [TBL] [Abstract][Full Text] [Related]
6. Maternal and neonatal outcomes associated with induction of labor after one previous cesarean delivery: A French retrospective study. Vecchioli E; Cordier AG; Chantry A; Benachi A; Monier I PLoS One; 2020; 15(8):e0237132. PubMed ID: 32764773 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of Propranolol to Reduce Cesarean Delivery in Prolonged Labor: A Randomized Controlled Trial. McCoy JA; Walheim L; McCabe MG; Levine LD Obstet Gynecol; 2023 Jul; 142(1):71-79. PubMed ID: 37290102 [TBL] [Abstract][Full Text] [Related]
9. Association between Maternal Serum Lipids and Intrapartum Oxytocin Requirements during Labor Induction and Augmentation. Frolova AI; Prifti KK; Raghuraman N; Carter EB; England SK; Stout MJ Am J Perinatol; 2024 May; 41(S 01):e1015-e1022. PubMed ID: 36384236 [TBL] [Abstract][Full Text] [Related]
10. Concurrent dinoprostone and oxytocin for labor induction in term premature rupture of membranes: a randomized controlled trial. Tan PC; Daud SA; Omar SZ Obstet Gynecol; 2009 May; 113(5):1059-1065. PubMed ID: 19384121 [TBL] [Abstract][Full Text] [Related]
11. Reducing neonatal morbidity by discontinuing oxytocin during the active phase of first stage of labor: a multicenter randomized controlled trial STOPOXY. Girault A; Goffinet F; Le Ray C; BMC Pregnancy Childbirth; 2020 Oct; 20(1):640. PubMed ID: 33081758 [TBL] [Abstract][Full Text] [Related]
12. Acupuncture or acupressure for induction of labour. Smith CA; Armour M; Dahlen HG Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002962. PubMed ID: 29036756 [TBL] [Abstract][Full Text] [Related]
13. Induction of labor using one dose vs multiple doses of misoprostol: a randomized controlled trial. Pimentel VM; Arabkhazaeli M; Moon JY; Wang A; Kapedani A; Bernstein PS; Tropper PJ Am J Obstet Gynecol; 2018 Jun; 218(6):614.e1-614.e8. PubMed ID: 29614276 [TBL] [Abstract][Full Text] [Related]
14. Intrapartum nipple stimulation therapy for labor induction: a randomized controlled external pilot study of acceptability and feasibility. Stark EL; Athens ZG; Son M Am J Obstet Gynecol MFM; 2022 Mar; 4(2):100575. PubMed ID: 35042047 [TBL] [Abstract][Full Text] [Related]
15. Titrated oral misoprostol for augmenting labour to improve maternal and neonatal outcomes. Vogel JP; West HM; Dowswell T Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD010648. PubMed ID: 24058051 [TBL] [Abstract][Full Text] [Related]
16. Maternal body mass index and oxytocin exposure in nulliparous women: is there an interaction associated with maternal and neonatal morbidities? Subramaniam A; Owen J; Campbell SB; Harper LM; Fitzwater JL; Edwards RK J Matern Fetal Neonatal Med; 2018 Aug; 31(15):2013-2018. PubMed ID: 28532287 [TBL] [Abstract][Full Text] [Related]
17. Comparison of delivery outcomes in low-dose and high-dose oxytocin regimens for induction of labor following cervical ripening with a balloon catheter: A retrospective observational cohort study. Kruit H; Nupponen I; Heinonen S; Rahkonen L PLoS One; 2022; 17(4):e0267400. PubMed ID: 35452451 [TBL] [Abstract][Full Text] [Related]
18. Continuous vs intermittent induction of labor with oxytocin in nulliparous patients: a randomized controlled trial. Bachar G; Abu-Rass H; Farago N; Justman N; Buchnik G; Chen YS; David CB; Goldfarb N; Khatib N; Ginsberg Y; Zipori Y; Weiner Z; Vitner D Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101176. PubMed ID: 37813304 [TBL] [Abstract][Full Text] [Related]
19. The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study. Lavoie A; McCarthy RJ; Wong CA Anesth Analg; 2015 Jul; 121(1):159-164. PubMed ID: 25902327 [TBL] [Abstract][Full Text] [Related]
20. High dose versus low dose oxytocin for augmentation of delayed labour. Mori R; Tokumasu H; Pledge D; Kenyon S Cochrane Database Syst Rev; 2011 Oct; (10):CD007201. PubMed ID: 21975767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]